Subscribe 

Drugmaker GSK investigates alleged bribery in Iraq

Drugmaker GlaxoSmithKline, already facing corruption accusations in China, is now investigating allegations of bribery in Iraq, the British company said on Sunday. The latest controversy centers on claims that the company hired government-employed physicians and pharmacists in Iraq as paid sales representatives to improperly boost use of its products.

Ben Hirschler of Reuters reports:

Drugmaker GlaxoSmithKline, already facing corruption accusations in China, is now investigating allegations of bribery in Iraq, the British company said on Sunday.

The latest controversy centers on claims that the company hired government-employed physicians and pharmacists in Iraq as paid sales representatives to improperly boost use of its products.